Search Results - "Khodavaisy, Sadegh"

Co‐Infection of Pulmonary Aspergillosis and Cryptococcal Meningitis in an HIV‐Positive Patient: A Case Report.

Authors: Hemmatian, Marjan Khodavaisy, Sadegh Kazemizadeh, Hossein et al.

Source: Case Reports in Infectious Diseases. 8/5/2025, Vol. 2025, p1-7. 7p.

Outcomes of Patients with COVID-19 and Fungal Coinfections: A Systematic Review and Meta-Analysis Study.

Authors: Khodavaisy, Sadegh Sarrafnia, Haleh Abdollahi, Alireza

Source: Iranian Journal of Pathology. Spring2024, Vol. 19 Issue 2, p137-147. 11p.

Iranian patients with diabetes and COVID-19-associated mucormycosis: Characteristics, manifestations, and mortality risk factors.

Authors: Salehi, Mohammadreza Esteghamati, Alireza Khodavaisy, Sadegh et al.

Source: International Journal of Diabetes in Developing Countries. Dec2024, Vol. 44 Issue 4, p704-710. 7p.

Port implantation-related bloodstream infection caused by Wickerhamomyces myanmarensis: A case report.

Authors: Aminasnafi, Ali Khodavaisy, Sadegh Moslem, Maryam et al.

Source: Current Medical Mycology. Mar2023, Vol. 9 Issue 1, p32-35. 4p.

Relapse of COVID-19-associated mucormycosis in patients receiving posaconazole as maintenance treatment.

Authors: Salehi, Mohammadreza Khodavaisy, Sadegh Sarvestani, Hasti Kamali et al.

Source: Journal of Infection in Developing Countries. 2024 Supplement, Vol. 18, pS163-S169. 7p.

Shifting etiological agents of dermatophytosis: a molecular epidemiological study from Iran.

Authors: Eshkaleti, Mahsa Naeimi Hashemi, Seyed Jamal Khodavaisy, Sadegh et al.

Source: Iranian Journal of Microbiology. Oct2025, Vol. 17 Issue 5, p854-860. 7p.

Investigation of the antifungal activity of panobinostat, tamoxifen, and miltefosine alone and in combination with some conventional antifungal drugs against fluconazole-resistant Candida species.

Authors: Amirzadeh-Ghasemi, Fatemeh Ghazvini, Roshanak Daie Khodavaisy, Sadegh et al.

Source: Iranian Journal of Microbiology. Oct2025, Vol. 17 Issue 5, p848-853. 6p.

Isolation and identification of Fusarium species from the water systems of ICUs and transplant wards of hospitals and determination of the in vitro susceptibilities of isolates to conventional antifungals.

Authors: Mirhasani, Fatemeh Daie-Ghazvini, Roshanak Hashemi, Seyed Jamal et al.

Source: Frontiers in Fungal Biology. 2025, p1-7. 7p.

Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report.

Authors: Sasani, Elahe Khodavaisy, Sadegh Salehi, Mohammadreza et al.

Source: Iranian Journal of Microbiology. Jun2024, Vol. 16 Issue 3, p428-433. 6p.

The first case of isolation of Magnusiomyces capitatus from the oral cavity of an addicted patient.

Authors: Ghojoghi, Aynaz Khodavaisy, Sadegh Mahmoudabadi, Ali Zarei et al.

Source: Journal of Infection in Developing Countries. Feb2024, Vol. 18 Issue 2, p309-314. 6p.

Proven pulmonary aspergillosis in a COVID-19 patient: A case report.

Authors: Khodavaisy, Sadegh Khajavirad, Nasim Hashemi, Seyed Jamal et al.

Source: Current Medical Mycology. Jun2021, Vol. 7 Issue 2, p39-42. 4p.

The effect of royal jelly and propolis alone and in combination on inhibition of Aspergillus parasiticus growth, aflatoxin production, and aflR gene expression.

Authors: Hamzeh Pour, Siavash Khodavaisy, Sadegh Mahmoudi, Shahram et al.

Source: Journal of Food Safety. Aug2020, Vol. 40 Issue 4, p1-7. 7p.

Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023).

Authors: Raeisabadi, Abbas Nosratabadi, Mohsen Abtahian, Zahra et al.

Source: BMC Infectious Diseases. 7/1/2025, Vol. 25 Issue 1, p1-16. 16p.

Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris.

Authors: Ahangarkani, Fatemeh Khodavaisy, Sadegh Mahmoudi, Shahram et al.

Source: Current Medical Mycology. Sep2019, Vol. 5 Issue 3, p26-30. 5p.

Investigation of the Antifungal Activity of Curcumin-Coated Gold Nanoparticles.

Authors: Mahmoudi, Shahram Amini, Seyed Mohammad Khodavaisy, Sadegh et al.

Source: Nanomedicine Research Journal. Spring2025, Vol. 10 Issue 2, p179-188. 10p.

Assessing the Efficacy of Chlorhexidine in Combating Most Important Causative Agents of Fungal Keratitis: An in Vitro Comparative Study With Seven Antifungal Agents.

Authors: Izadi, Alireza dos Santos, Claudy Oliveira Mohamadi, Afsaneh et al.

Source: Current Eye Research. Mar2025, Vol. 50 Issue 3, p252-257. 6p.

Molecular typing of clinical and environmental Aspergillus fumigatus isolates from Iran using microsatellites.

Authors: Badali, Hamid Shokohi, Tahereh Khodavaisy, Sadegh et al.

Source: Current Medical Mycology. Mar2021, Vol. 7 Issue 1, p25-30. 6p.

COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.

Authors: Abdorahimi, Mahsa Pakdel, Farzad Salehi, Mohammadreza et al.

Source: Mycopathologia. Oct2023, Vol. 188 Issue 5, p783-792. 10p.

Subglottic mucormycosis in a COVID-19 patient: a rare case report.

Authors: Amirzargar, Behrooz Jafari, Mehrdad Ahmadinejad, Zahra et al.

Source: Oxford Medical Case Reports. Jul2022, Vol. 2022 Issue 7, p1-4. 4p.

High Prevalence of Azole‐Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?

Authors: Bandegani, Azadeh Abastabar, Mahdi Sharifisooraki, Joobin et al.

Source: Mycoses. Sep2024, Vol. 67 Issue 9, p1-9. 9p.